Kirk A Rockett Selected Research

IGF-I-IGFBP-3 complex

9/2016	Tumour necrosis factor alpha promoter polymorphism, TNF-238 is associated with severe clinical outcome of falciparum malaria in Ibadan southwest Nigeria.
6/2014	Association of candidate gene polymorphisms and TGF-beta/IL-10 levels with malaria in three regions of Cameroon: a case-control study.
1/2013	Association of cytokine and Toll-like receptor gene polymorphisms with severe malaria in three regions of Cameroon.
1/2012	Investigation of host candidate malaria-associated risk/protective SNPs in a Brazilian Amazonian population.
5/2010	Candidate malaria susceptibility/protective SNPs in hospital and population-based studies: the effect of sub-structuring.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kirk A Rockett Research Topics

Disease

37	Malaria 03/2021 - 08/2003
8	Infections 01/2020 - 04/2007
6	Sickle Cell Trait 08/2018 - 04/2007
6	Glucosephosphate Dehydrogenase Deficiency 01/2016 - 08/2009
4	Iron Deficiencies 01/2020 - 02/2008
4	Anemia 01/2016 - 02/2008
4	Falciparum Malaria (Plasmodium falciparum Malaria) 08/2015 - 08/2003
3	Cerebral Malaria 01/2018 - 01/2013
3	Hemolysis 02/2015 - 04/2007
2	Inflammation (Inflammations) 01/2020 - 01/2016
2	Thalassemia 01/2017 - 03/2014
2	Sickle Cell Anemia (Hemoglobin S Disease) 01/2016 - 02/2008
2	Cicatrix (Scar) 11/2015 - 01/2008
2	Trachoma 06/2010 - 01/2008
1	Communicable Diseases (Infectious Diseases) 06/2016
1	Bacteremia 06/2016
1	Parasitemia 08/2015
1	Hyperthermia 01/2013
1	Hemolytic Anemia 01/2012
1	Neonatal Jaundice 01/2012
1	Autoimmune Diseases (Autoimmune Disease) 03/2009
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 03/2009
1	Iron-Deficiency Anemia (Anemia, Iron Deficiency) 11/2008
1	Vascular Diseases (Vascular Disease) 09/2003
1	Diabetes Mellitus 09/2003

Drug/Important Bio-Agent (IBA)

7	Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA 01/2017 - 08/2009
6	Blood Group Antigens (Blood Groups)IBA 08/2018 - 02/2008
5	Interleukin-10 (Interleukin 10)IBA 08/2018 - 01/2008
5	IGF-I-IGFBP-3 complex FDA Link 09/2016 - 05/2010
4	DNA (Deoxyribonucleic Acid)IBA 03/2021 - 05/2010
4	Antimalarials (Antimalarial Agents)IBA 03/2021 - 01/2014
4	HaptoglobinsIBA 03/2014 - 04/2007
4	Lymphotoxin-alpha (Lymphotoxin)IBA 03/2009 - 11/2008
3	IronIBA 01/2020 - 11/2008
3	EnzymesIBA 01/2016 - 02/2008
3	Hemoglobins (Hemoglobin)IBA 01/2016 - 02/2008
3	Oxidants (Oxidizing Agents)IBA 01/2012 - 04/2007
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2009 - 11/2008
2	Glycophorins (Glycophorin C)IBA 01/2021 - 10/2015
2	Sickle HemoglobinIBA 01/2017 - 08/2015
2	Folic Acid (Vitamin M)FDA LinkGeneric 01/2016 - 02/2008
2	AntigensIBA 08/2015 - 01/2013
2	glucose-6-phosphate dehydrogenase A-IBA 07/2014 - 08/2009
1	Amodiaquine (Camoquin)FDA Link 03/2021
1	pyrimethamine drug combination fanasil (Fansidar)FDA Link 03/2021
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Interferon-gamma (Interferon, gamma)IBA 01/2020
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 08/2018
1	Complement Receptors (Complement Receptor)IBA 01/2018
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2017
1	Interleukin-13IBA 01/2017
1	Long Noncoding RNAIBA 06/2016
1	Untranslated RNA (Noncoding RNA)IBA 06/2016
1	Proteins (Proteins, Gene)FDA Link 01/2016
1	CateninsIBA 01/2016
1	Heparitin Sulfate (Heparan Sulfate)IBA 01/2016
1	Cadherins (E-Cadherin)IBA 01/2016
1	H-cadherin (T-cadherin)IBA 01/2016
1	Glycoproteins (Glycoprotein)IBA 01/2016
1	Cell Surface ReceptorsIBA 11/2015
1	Immunoglobulin E (IgE)IBA 08/2015
1	AntibodiesIBA 08/2015
1	Merozoite Surface Protein 1 (MSA1)IBA 08/2015
1	Hemoglobin CIBA 08/2015
1	Primaquine FDA Link 09/2014
1	Transforming Growth Factor beta (TGF-beta)IBA 06/2014
1	Nitrogen OxidesIBA 06/2014
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2013
1	CytokinesIBA 01/2013
1	MethemoglobinIBA 01/2012
1	Pharmaceutical PreparationsIBA 01/2011
1	GoldIBA 05/2010
1	Adenylyl Cyclases (Adenylyl Cyclase)IBA 04/2010
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 04/2010
1	GTP-Binding Proteins (G-Protein)IBA 04/2010
1	GTP-Binding Protein beta SubunitsIBA 04/2010
1	G-Protein-Coupled Receptor Kinase 2IBA 04/2010
1	Insulin (Novolin)FDA Link 03/2009
1	HLA-B Antigens (HLA-B)IBA 02/2009
1	Interferon Regulatory Factor-1 (Interferon Regulatory Factor 1)IBA 01/2009
1	GTP-Binding Protein alpha SubunitsIBA 12/2008
1	Peptides (Polypeptides)IBA 11/2008
1	P-2 (P 2)IBA 02/2008
1	ABO Blood-Group SystemIBA 02/2008
1	GlycosyltransferasesIBA 02/2008
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 04/2007
1	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2003
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 08/2003

Therapy/Procedure

1	Chemoprevention 03/2021